Catalyst Biosciences Inc. Daily Stock Analysis

Daily Stock Analysis, CBIO, Catalyst Biosciences Inc, priceseries

Catalyst Biosciences Inc. Daily Stock Analysis
Stock Information
Open
0.65
Close
0.67
High
0.70
Low
0.65
Previous Close
0.67
Daily Price Gain
0.00
YTD High
1.02
YTD High Date
Jan 3, 2022
YTD Low
0.50
YTD Low Date
Feb 16, 2022
YTD Price Change
-0.33
YTD Gain
-32.66%
52 Week High
6.24
52 Week High Date
Mar 11, 2021
52 Week Low
0.50
52 Week Low Date
Feb 16, 2022
52 Week Price Change
-5.12
52 Week Gain
-88.37%
Recent priceSeries Trade Signals

These are sample algorithmic trades based on actual market data.

Trade Type
Entry Date
Entry Price
Exit Date
Exit Price
Trade Hold Time
Gain
Trade Record
LONG
Jan 12. 2017
10.20
Jan 13. 2017
10.85
1 Trading Days
6.37%
Link
LONG
Feb 13. 2017
9.50
Feb 14. 2017
10.16
1 Trading Days
6.95%
Link
LONG
Mar 28. 2017
15.01
Mar 29. 2017
16.55
1 Trading Days
10.29%
Link
LONG
Sep 12. 2017
3.62
Oct 12. 2017
5.29
22 Trading Days
46.16%
Link
LONG
Nov 15. 2017
4.89
Jan 16. 2018
14.46
40 Trading Days
195.73%
Link
LONG
Jan 17. 2018
17.15
Jan 30. 2018
20.88
9 Trading Days
21.77%
Link
LONG
Apr 12. 2018
24.76
May 3. 2018
27.73
15 Trading Days
11.99%
Link
LONG
Mar 11. 2019
8.53
Mar 21. 2019
9.23
8 Trading Days
8.20%
Link
LONG
Apr 1. 2019
8.93
Apr 11. 2019
9.59
8 Trading Days
7.37%
Link
LONG
Apr 6. 2020
4.33
May 1. 2020
5.70
18 Trading Days
31.67%
Link
LONG
May 19. 2020
6.39
Jun 11. 2020
7.45
16 Trading Days
16.65%
Link
LONG
Oct 13. 2020
4.79
Oct 20. 2020
5.11
5 Trading Days
6.63%
Link
LONG
Aug 23. 2021
4.11
Sep 3. 2021
4.50
9 Trading Days
9.61%
Link
Company Information
Stock Symbol
CBIO
Exchange
NasdaqGS
Company URL
http://www.catalystbiosciences.com
Company Phone
6507450655
CEO
Nassim Usman
Headquarters
California
Business Address
260 LITTLEFIELD AVENUE, SOUTH SAN FRANCISCO, CA 94080
Sector
-
Industry Category
-
Industry Group
-
CIK
0001124105
About

Catalyst Biosciences, Inc. is a clinical-stage biopharmaceutical company. It focuses on creating and developing novel medicines to address serious medical conditions for patients who need new or better treatment options. The company was founded on August 5, 2002 and is headquartered in South San Francisco, CA.

Description

Targacept, Inc., a biopharmaceutical company, engages in the development of neuronal nicotinic receptors (NNR) therapeutics for the treatment of nervous system and gastrointestinal/genitourinary diseases and disorders.

TCHANNELS® is a Registered Trademark with USPTO

Some images used on this site have been taken from Unsplash

Legal Information

Useful Links

Contact Us

PO Box 2574, Sunnyvale
California 94087-0574, USA
Phone: 408-940-5056
Email: Click to send us an Email

Risks of Algorithmic Trading: Before investing please read our disclosure on Risks of Algorithmic Trading.

DISCLAIMER All investments entail inherent risk. This research seeks to assist investors in determining when to buy and when to sell to attempt to maximize profits or minimize losses. All final investment decisions are yours and as a result you could make or lose money. priceSeries.com, its employees and/or its affiliates and family members may from time to time take positions in the open market or otherwise with respect to the securities discussed. priceSeries.com, its employees and/or affiliates do not have stock ownership equal to or greater than 1% of the outstanding stock of the covered company nor does any employee of priceSeries.com sit on the Board of Directors of any covered company. priceSeries.com is not a broker/dealer, and the firm does not underwrite securities, manage assets or perform investment banking activities. The statements made herein include information obtained from sources believed to be reliable, but no independent verification has been made and we do not guarantee its accuracy or completeness.

U.S. Government Required Disclaimer - Commodity Futures Trading Commission
Futures and Options trading has large potential rewards, but also large potential risk. You must be aware of the risks and be willing to accept them in order to invest in the futures and options markets. Don't trade with money you can't afford to lose. This is neither a solicitation nor an offer to Buy/Sell futures or options. No representation is being made that any account will or is likely to achieve profits or losses similar to those discussed on this web site. The past performance of any trading system or methodology is not necessarily indicative of future results.

CFTC RULE 4.41 - HYPOTHETICAL OR SIMULATED PERFORMANCE RESULTS HAVE CERTAIN LIMITATIONS. UNLIKE AN ACTUAL PERFORMANCE RECORD, SIMULATED RESULTS DO NOT REPRESENT ACTUAL TRADING. ALSO, SINCE THE TRADES HAVE NOT BEEN EXECUTED, THE RESULTS MAY HAVE UNDER-OR-OVER COMPENSATED FOR THE IMPACT, IF ANY, OF CERTAIN MARKET FACTORS, SUCH AS LACK OF LIQUIDITY. SIMULATED TRADING PROGRAMS IN GENERAL ARE ALSO SUBJECT TO THE FACT THAT THEY ARE DESIGNED WITH THE BENEFIT OF HINDSIGHT. NO REPRESENTATION IS BEING MADE THAT ANY ACCOUNT WILL OR IS LIKELY TO ACHIEVE PROFIT OR LOSSES SIMILAR TO THOSE SHOWN.

2016 © priceSeries.com All Rights Reserved. Privacy Policy | Subscriber Agreement | Risks of Algorithmic Trading